You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

docetaxel

Showing 51 - 75 of 1,353
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer Trial in Shenyang (ARX788, Pyrotinib maleate, Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital affiliated to China Medical University
Jun 21, 2022

Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)

Recruiting
  • Recurrent Non-small Cell Lung Cancer
  • Changchun, Jilin, China
  • +2 more
May 3, 2022

Prostate Cancer, Prostate Tumors, Tumors, Prostatic Trial run by the NCI (PROSTVAC-V, PROSTVAC-F, Docetaxel)

Active, not recruiting
  • Prostate Cancer
  • +2 more
  • PROSTVAC-V
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 14, 2022

Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

Recruiting
  • Oral Squamous Cell Carcinoma
  • +3 more
  • Toripalimab (anti-programmed death-1 inhibitor)
  • +4 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, Shanghai Jiao Tong University School of
Oct 8, 2022

Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)

Completed
  • Prostate Cancer
  • Docetaxel
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 12, 2022

Prostatic Tumor Trial in Seoul (Docetaxel, Androgen-Deprivation Therapy (ADT))

Active, not recruiting
  • Prostatic Neoplasm
  • Docetaxel
  • Androgen-Deprivation Therapy (ADT)
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 6, 2022

Prostate Cancer Trial in Vancouver, Montreal, Quebec City (177Lu-PSMA-617, Docetaxel)

Suspended
  • Prostate Cancer
  • Vancouver, British Columbia, Canada
  • +3 more
Jun 13, 2022

Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With

Enrolling by invitation
  • Gastric Cancer
  • Gastrectomy
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan hospital
May 1, 2022

Metastatic Castrate Resistant Prostate Cancer Trial in Boston, Detroit, Columbus (Docetaxel, Radium 223)

Recruiting
  • Metastatic Castrate Resistant Prostate Cancer
  • Docetaxel
  • Radium 223
  • Boston, Massachusetts
  • +3 more
Feb 22, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Docetaxel, Nivolumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Shanghai, Shanghai, China
    Guo Ye
Jan 27, 2022

NSCLC Trial in Ann Arbor (Pevonedistat, Docetaxel)

Terminated
  • Non-small Cell Lung Cancer
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Dec 16, 2021

Gastric Cancer Trial in China (IN10018, Docetaxel)

Completed
  • Gastric Cancer
  • Anyang, Henan, China
  • +7 more
Nov 15, 2022

Nsclc Trial in Beijing (HL-085, Docetaxel)

Terminated
  • Nsclc
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science
Nov 29, 2021

Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou (Docetaxel,

Recruiting
  • Metastatic Gastric Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Docetaxel
  • +2 more
  • Guangzhou, Guangdong, China
    The Sixth Affiliated hosipital, Sun Yat-Sen University
Jan 20, 2022

Cancer of Head and Neck Trial in Lyon (Docetaxel, Cisplatin, Fluoro Uracil)

Recruiting
  • Cancer of Head and Neck
  • Docetaxel
  • +2 more
  • Lyon, France
    Centre Leon Berard
Mar 10, 2022

Advanced Cancer Trial (AB801, Zimberelimab, Docetaxel)

Not yet recruiting
  • Advanced Cancer
  • (no location specified)
Nov 1, 2023

Prostate Cancer Trial in Boston (Docetaxel, Androgen Hormonal Suppression and Radiation, Androgen Suppression Therapy and

Completed
Has Results
  • Prostate Cancer
  • Docetaxel
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute and (Sanofi-Aventis Consortium)
Jan 6, 2022

HER2-positive Breast Cancer, Adjuvant Therapy Trial in Hangzhou (Paclitaxel, Trastuzumab, Docetaxel)

Recruiting
  • HER2-positive Breast Cancer
  • Adjuvant Therapy
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Dec 26, 2021

Oncology, Neuroendocrine Carcinoma Trial in United Kingdom (Liposomal Irinotecan, Fluorouracil, Folinic Acid)

Active, not recruiting
  • Oncology
  • Neuroendocrine Carcinoma
  • Liposomal Irinotecan
  • +3 more
  • Glasgow, United Kingdom
  • +3 more
Dec 2, 2022

Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

Not yet recruiting
  • Breast Neoplasms
  • Guangzhou, Gangdong, China
    Sun-yat sen university cancer center
Jul 30, 2023

Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Metastatic Non-Small Lung Cell Cancer
  • +4 more
  • Docetaxel
  • +2 more
  • Atlanta, Georgia
    Winship Cancer Institute of Emory University
Oct 19, 2022

Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • quaratusugene ozeplasmid
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 12, 2022

Non Small Cell Lung Cancer (NSCLC) Trial in United States (SPI-1620, Docetaxel)

Terminated
  • Non Small Cell Lung Cancer (NSCLC)
  • Cincinnati, Ohio
  • +4 more
Oct 8, 2021

Solid Tumor Trial in Denmark, Lithuania, Sweden (Docetaxel)

Terminated
  • Solid Tumor
  • Docetaxel
  • Copenhagen, Denmark
  • +3 more
Dec 22, 2021

Ewing's Sarcoma Trial in United States (Vigil, Temozolomide, Irinotecan)

Completed
Has Results
  • Ewing's Sarcoma
  • Vigil
  • +4 more
  • Little Rock, Arkansas
  • +5 more
Dec 20, 2022